A c c e p t e d A r t i c l e This article has been accepted for publication and undergone full peer review but has not been through the copyediting , typesetting , pagination and proofreading process , which may lead to differences between this version and the Version of Record . Please cite this article as doi : 10 . 1002 / 1878 - 0261 . 12155 Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . This is an open access article under the terms of the Creative Commons Attribution License , which permits use , distribution and reproduction in any medium , provided the original work is properly cited . DR . LETIZIA LANZETTI ( Orcid ID : 0000 - 0001 - 7541 - 5524 ) Article type : Review Emerging functions of the EGFR in cancer Sara Sigismund 1 , Daniele Avanzato 2 , 3 and Letizia Lanzetti 2 , 3 1 IFOM , Fondazione Istituto FIRC di Oncologia Molecolare , Via Adamello 16 , Milan , Italy ; 2 Dept . of Oncology , University of Torino Medical School , Torino , Italy ; 3 Candiolo Cancer Institute , FPO - IRCCS , Candiolo , Torino , Italy . Running title : Novel functions of the EGFR in cancer Keywords : EGFR , cancer , membrane trafficking , signal transduction A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Correspondence should be addressed to : Sara Sigismund , PhD Letizia Lanzetti IFOM , The FIRC Institute for IRCCS Molecular Oncology Foundation Candiolo Cancer Institute Via Adamello 16 , 20139 Milan Str . Provinciale 142 , 10060 Candiolo Italy Italy Tel . + 39 - 02 - 574303285 Tel . + 39 - 011 - 9933255 E - mail : sara . sigismund @ ifom . eu E - mail : letizia . lanzetti @ ircc . it Abstract The physiological function of the Epidermal Growth Factor Receptor ( EGFR ) is to regulate epithelial tissue development and homeostasis . In pathological settings , mostly in lung and breast cancer and in glioblastoma , the EGFR is a driver of tumorigenesis . Inappropriate activation of the EGFR in cancer mainly results from amplification and point mutations at the genomic locus , but transcriptional upregulation or ligand overproduction due to autocrine / paracrine mechanisms have also been described . Moreover , the EGFR is increasingly recognized as a biomarker of resistance in tumors , since its amplification or secondary mutations have been found to arise under drug pressure . This evidence , in addition to the prominent function that this receptor plays in normal epithelia , has prompted intense investigations into the role of the EGFR both at physiological and pathological level . Despite the large body of knowledge obtained over the last two decades , previously unrecognized ( herein defined as “non - canonical” ) functions of the EGFR are currently emerging . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Here , we will initially review the canonical ligand - induced EGFR signaling pathway , with particular emphasis to its regulation by endocytosis and subversion in human tumors . We will then focus on the most recent advances in uncovering non - canonical EGFR functions in stress - induced trafficking , autophagy and energy metabolism , with a perspective on future therapeutic applications . Introduction The EGFR belongs to the ErbB family of receptor tyrosine kinases ( RTKs ) and exerts critical functions in epithelial cell physiology ( Schlessinger , 2014 ) . It is frequently mutated and / or overexpressed in different types of human cancers and is the target of multiple cancer therapies currently adopted in the clinical practice ( Yarden and Pines , 2012 ) . Early studies of the EGFR pathway started with the discovery of EGF in 1963 by Stanley Cohen and , later in the ' 80s , of the EGFR gene . Since then , biochemical , structural , and genetic studies have depicted the molecular mechanisms underlying receptor transphosphorylation , which usually occurs in response to ligand stimulation , and the consequent activation of the intracellular signaling cascade . This cascade consists in the activation of multiple pathways that deliver the information from the cell surface , and the intracellular vesicular compartments , to the nucleus leading to the activation of genes responsible for cell proliferation , survival and differentiation ( Lemmon and Schlessinger , 2010 ; Schlessinger , 2014 ) . The best characterized functions of the EGFR are in the context of ligand - and kinase - dependent activation , i . e . , the ‘canonical’ EGFR signaling pathway ( Lemmon and Schlessinger , 2010 ) . However , novel functions , both kinase - dependent and independent , have been recently identified . They reveal unexpected roles of the EGFR , such as in the regulation of autophagy and metabolism ( Tan et al . , 2016a ) . These non - canonical functions are A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . generally induced by cellular and environmental stresses . Several of these ‘stress pathways’ are activated in cancer cells to provide them with a survival advantage and resistance to therapy ( Jutten et al . , 2013 ; Tan et al . , 2016a ) . This has led to an emerging concept , that concomitant targeting of EGFR and stress pathways might offer a window of opportunity in cancer treatment . 1 . Canonical ligand - dependent EGFR signaling pathway Under unstimulated conditions , the EGFR is mainly found in an auto - inhibited , dimerization - incompetent , state at the plasma membrane ( PM ) . Ligand binding promotes receptor dimerization , which determines a series of structural rearrangements that are conveyed to the cytoplasmic domain allowing the formation of asymmetric dimers between the two juxtaposed catalytic domains [ ( Zhang et al . , 2006 ) and Figure 1A ] . These events lead to the allosteric activation of the EGFR kinase and to the trans - autophosphorylation of critical tyrosine residues in the cytoplasmic receptor tail , thereby triggering the signaling cascade [ ( Lemmon et al . , 2014 ) ] . For in - depth molecular details of EGFR activation , we refer the reader to recent reviews ( Kovacs et al . , 2015 ; Lemmon et al . , 2014 ) . Ligand - induced EGFR phosphorylation and conformational changes occurring in the intracellular tail lead also to the recruitment of the endocytic machinery that mediates receptor endocytosis , with internalization rates that are ~ tenfold higher for ligand - bound than for unliganded EGFR ( Conte and Sigismund , 2016 ) . The EGFR can heterodimerize with other ErbB family members , ErbB2 , ErbB3 and ErbB4 ( Lemmon et al . , 2014 ) , with critical effects on receptor trafficking and signaling ( Lenferink et al . , 1998 ) . Indeed , heterodimers have a reduced ligand - binding strength , leading to ligand dissociation in endosomes , and they are unable to recruit Cbl and the endocytic machinery as efficiently as EGFR homodimers ( Baulida et al . , 1996 ; Lenferink et al . , 1998 ; Levkowitz et al . , 1998 ; Waterman et al . , 1999 ) . Signaling from heterodimers is therefore enhanced and predicted to be more oncogenic than signaling from homodimers . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Seven EGFR ligands have been described to date , which have been shown to induce specific cellular responses and intracellular trafficking events both in vitro and in vivo ( Roepstorff et al . , 2009 ; Wilson et al . , 2012 ; Yang et al . , 2017 ) . In some cases , these differences are determined by the different strength of the ligand - receptor interaction , which dictates whether the ligand dissociates ( as in the case of TGF  ) or not ( as in the case of EGF ) from the receptor in the mild - acidic pH of the endosomes , favoring EGFR recycling or degradation , respectively . In other instances , the different signaling properties of the various ligands have been attributed to their ability to differentially stabilize the EGFR dimers , therefore determining specific signaling outputs ( Freed et al . , 2017 ) . Once activated at the PM , the EGFR also undergoes ubiquitination by the E3 ligase Cbl in complex with the adaptor molecule Grb2 ( Levkowitz et al . , 1998 ; Sigismund et al . , 2013 ; Waterman et al . , 2002 ) . EGFR ubiquitination is threshold controlled by EGF concentration ( Sigismund et al . , 2013 ) and occurs on several lysine residues within the kinase domain ( Huang et al . , 2006 ) . In specific cell contexts , EGFR ubiquitination works as a signal for receptor internalization into the non - clathrin endocytic ( NCE ) pathway . At later stages of trafficking , ubiquitination becomes a common requirement to target receptors to lysosomal degradation ( see Section 1 . 1 ) . Ligand - dependent EGFR activation transduces multiple signaling pathways , including the Ras / MAPK pathway , the PI3K / AKT pathway , and the phospholipase C ( PLC ) / protein kinase C ( PKC ) signaling cascade ( Lemmon and Schlessinger , 2010 ) . Canonical EGFR signaling is critical for several cellular functions including survival , proliferation , differentiation and motility . The quality , the amplitude and the duration of these signaling events are tightly regulated by compartmentalization and trafficking of the EGFR along the endocytic pathway , as discussed in the following paragraphs . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . 1 . 1 . Temporal regulation of EGFR signaling by endocytosis The first step in the regulation of EGFR signaling takes place at the PM , where the EGFR is internalized through multiple endocytic pathways with different morphological , molecular and kinetic features that influence receptor activity and fate ( Barbieri et al . , 2016 ; Bergeron et al . , 2016 ) . Both clathrin - mediated endocytosis ( CME ) and several non - clathrin endocytic ( NCE ) pathways are involved in EGFR internalization ( Barbieri et al . , 2016 ) . EGFR - CME is active at all ligand concentrations in all type of cells ( Carpentier et al . , 1982 ; Goh et al . , 2010 ; Hanover et al . , 1984 ; Jiang et al . , 2003 ; Sigismund et al . , 2008 ; Sorkin and Carpenter , 1993 ) . Conversely , the EGFR - NCE pathways - despite their molecular and morphological differences - are generally activated at higher , but still physiologically - relevant , EGF doses (  10 ng / ml ) and their significance is cell - context dependent [ ( Boucrot et al . , 2015 ; Caldieri et al . , 2017 ; Orth et al . , 2006 ) also reviewed in ( Barbieri et al . , 2016 ) ] . The molecular mechanisms underlying CME are well defined , with clathrin , adaptor protein 2 ( AP2 ) and the large GTPase dynamin being the major players [ see ( Kirchhausen et al . , 2014 ; McMahon and Boucrot , 2011 ) for recent reviews ] . CME controls EGFR signaling through various mechanisms . At the PM , clustering of EGFR in clathrin - coated pits ( CCPs ) is required to optimize receptor phosphorylation , and to amplify and spatially constrain EGFR signaling ( Garay et al . , 2015 ; Ibach et al . , 2015 ) . AP2 exerts a critical function during the assembly of CCPs and it is essential to maintain the right vesicle size , with predictable consequences for receptor clustering and signaling ( Aguet et al . , 2013 ; Kadlecova et al . , 2017 ; Miller et al . , 2015 ) . In addition to AP2 , dynamin and the cargo itself tightly regulate the timing of CCP assembly allowing for receptor clustering and productive signaling ( Loerke et al . , 2009 ) . Some non - small cell lung cancer ( NSCLC ) cells show an aberrantly accelerated CME , with deregulated CCP initiation and maturation ( Chen et al . , 2017 ) . This phenotype has been linked to the activation of the neuronal dynamin isoform , dynamin1 ( dyn1 ) , in non - neuronal cells , and / or to the overexpression of the clathrin - light chain b [ CLCb ( Chen et al . , 2017 ) ] . The increased uncontrolled CME rate causes increased EGFR recycling and signaling through A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . AKT , promoting cancer cell survival ( Chen et al . , 2017 ) . Interestingly , both dyn1 and CLCb are upregulated in NSCLC and breast cancer [ reviewed in ( Schmid , 2017 ) ] . In instances in which NCE is activated in parallel to CME , the integration of the two pathways is critical in determining the final signaling response . For instance , in HeLa and in other epithelial cells , CME and NCE determine opposing receptor fates ( Sigismund et al . , 2008 ) : CME mainly induces receptor recycling ( with limited EGFR degradation ) , while NCE – which requires EGFR ubiquitination as an internalization signal ( Sigismund et al . , 2013 ; Sigismund et al . , 2005 ) – targets the majority of internalized EGFRs to degradation in the lysosome . In this way , CME , which is active at low EGF concentrations , directs the EGFR / EGF complex away from degradation and towards recycling to maintain signaling when ligand is limited . In addition , through recycling , CME also serves to prolong EGFR signaling , a requirement critical to achieve a productive proliferative response , and to polarize EGFR signaling to specific regions of the PM ( Bisi et al . , 2013 ; Sigismund et al . , 2012 ) . Polarized trafficking of cargo proteins to regions of the PM represents one of the most frequently altered functions of endo / exocytosis in cancer as it is primarily involved in migration and invasion of metastatic cells and in maintenance of epithelial cell polarity [ reviewed in ( Lanzetti and Di Fiore , 2017 ) ] . EGFR - NCE is activated only at high EGF concentrations and is critical for long - term attenuation of EGFR signaling by directing EGFRs to lysosomal degradation . Recently , the mechanism governing EGFR - NCE has been elucidated . This endocytic route depends on the function of an endoplasmic reticulum ( ER ) - resident protein , reticulon 3 ( RTN3 ) , which is involved in the formation of contact sites between the ER and regions of the PM where EGFR - NCE occurs [ ( Caldieri et al . , 2017 ) , also discussed in Section 2 . 1 ] . This modality of EGFR - NCE appears to act as a safeguard against excessive EGFR signaling , and might represent a mechanism for modulating EGFR signaling at specific PM regions where polarized functions take place , an issue that deserves further investigation . Other types of EGFR - NCE occur at specific PM locations and are connected with cell migration . They include : i ) the macropinocytic - like pathway that originates , in mouse and human fibroblasts , A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . from actin - based membrane ruffles , defined as circular or dorsal ruffles ( Orth et al . , 2006 ) , implicated in three - dimensional cell motility and extracellular matrix degradation ( Suetsugu et al . , 2003 ) and ii ) the fast endophilin - mediated endocytosis ( FEME ) . This latter pathway is involved in the internalization of several G - protein - coupled receptors ( GPCRs ) and RTKs , including the EGFR , and is active at the leading edge of migrating cells suggesting its involvement in polarized signaling during cell migration ( Boucrot et al . , 2015 ) . Once internalized , EGFRs reach the early endosomes ( EEs ) , a further ‘level’ in the regulation of EGFR signaling . At this station , EGFRs are sorted towards different fates , recycling or degradation [ reviewed in ( Wandinger - Ness and Zerial , 2014 ) ] . Receptor recycling is usually the default pathway . Escape from recycling is determined by EGFR ubiquitination , which is an active signal recognized by the ESCRT ( endosomal sorting complexes required for transport ) complexes that , through a step - wise process , sort receptors into multivesicular bodies ( MVBs ) and into lysosomes for degradation [ reviewed in ( Raiborg and Stenmark , 2009 ; Wollert et al . , 2009 ) ] . Besides sorting , endosomes work as platforms for EGFR signaling . Here signals originating at the PM can be prolonged - in order to achieve a productive signaling response - and / or diversified - by assembling specific signaling complexes [ reviewed in ( Villasenor et al . , 2016 ) ] . Furthermore , the endosome fusion and fission machinery tightly controls EGFR signaling by keeping the number of EGFR clusters per endosome constant over a wide range of EGF concentrations ( Villasenor et al . , 2015 ) , thus , conferring robustness to the system . Varying the number of EGFR clusters per endosome through alteration of the endosome fission / fusion rate critically impacts the EGFR signaling output , e . g . proliferation vs . differentiation ( Villasenor et al . , 2015 ) . A novel regulatory mechanism occurring at the EEs has been recently described , which is able to sense the amount of EGFRs trafficking towards the endosomes and to induce de novo receptor biosynthesis and exocytosis , in order to preserve EGFR levels at the PM ( Scharaw et al . , 2016 ) . When cells are continuously stimulated with high EGF doses , the transcription factor RNF11 translocates A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . from the EEs to the nucleus where it induces transcription of genes required for EGFR transport to the PM ( Scharaw et al . , 2016 ) . How RNF11 senses the amount of internalized EGFR at the EEs remains an open question . 1 . 2 . EGFR cancer mutants divert from the normal trafficking itinerary EGFR signaling is frequently altered in several human cancers due to EGFR gene amplification and / or protein overexpression , mutations or in - frame deletions [ ( Roskoski , 2014 ) . The most frequent mutations in glioblastoma and lung cancer are illustrated in Figure 1B ; this figure also includes mutations found in colorectal cancers that are resistant to antibodies - mediated EGFR blockade ] . These genetic lesions often occur concomitantly with increased EGFR ligand production due to autocrine or paracrine loops ( Wilson et al . , 2009 ; Wilson et al . , 2012 ) . In many cases , EGFR genetic alterations determine abnormal EGFR trafficking , which contributes to increased signaling and tumor development . For instance , the increase in EGFR density at the PM due to EGFR amplification / overexpression was shown to stimulate receptor homo - and hetero - dimerization leading to kinase activation ( Chung et al . , 2010 ; Sawano et al . , 2002 ; Wiley , 1988 ; Wilson et al . , 2009 ) . In particular , heterodimers with the ligand - orphan receptor ErbB2 are constitutively active , evade receptor ubiquitination and degradation , and are mostly recycled back to the PM , thereby producing sustained signaling and cell proliferation ( Mellman and Yarden , 2013 ; Schneider and Yarden , 2016 ) . In agreement , saturation of the endocytic and / or the ubiquitination machinery has been proposed as a mechanism underlying sustained signaling in EGFR - overexpressing cancer cells ( Capuani et al . , 2015 ; French et al . , 1994 ; Wiley , 1988 ) . Oncogenic EGFR mutations and large genetic rearrangements ( as observed in glioblastoma , brain , lung , breast and ovarian cancers ) often cause altered receptor endocytosis , which contributes to increased signaling properties ( Yarden and Pines , 2012 ) . In some cases , mutations directly disrupt the recruitment site of the E3 ligase , Cbl , in the intracellular domain of the receptor [ i . e . , EGFRvIV and EGFRvV mutants ] , thereby affecting receptor ubiquitination and lysosomal degradation ( Roskoski , A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . 2014 ) . In other instances , mutations are located in the extracellular domain ( i . e . , EGFRvIII ) , leading to ligand - independent receptor activation ( Grandal et al . , 2007 ; Han et al . , 2006 ; Schmidt et al . , 2003 ) . Unexpectedly , these mutations also caused hypo - phosphorylation of the intracellular tyrosine residue 1045 , the direct Cbl binding site , via an unknown mechanism . In this way , receptor ubiquitination and turnover are affected , resulting in sustained signaling ( Grandal et al . , 2007 ; Han et al . , 2006 ; Schmidt et al . , 2003 ) . Somatic EGFR activating mutations have been detected in ~ 15 - 20 % of non - small cell lung cancer ( NSCLC ) patients ( Yun et al . , 2007 ) . One of the most frequent mutations , L858R , despite having a more highly phosphorylated Cbl - binding site than the wild - type receptor , is impaired in Cbl recruitment and receptor ubiquitination , again affecting trafficking towards the lysosome and receptor degradation , with consequent signal upregulation ( Kon et al . , 2014 ; Shtiegman et al . , 2007 ) . Increased hetero - dimerization of this mutant with ErbB2 has been proposed to cause this behavior ( Kon et al . , 2014 ) . Finally , it is important to stress that besides oncogenic alterations , inappropriate activation of the EGFR in cancer can originate from derailed receptor endocytosis and trafficking ( Mellman and Yarden , 2013 ) . This is achieved by two mechanisms : either mutated RTKs hijack the endocytic apparatus , which , in turn , fosters their signaling properties , or altered endocytic / trafficking genes potentiate the duration and the amplitude of the signal ( Sigismund et al . , 2012 ) . Indeed , alterations in the balance between receptor recycling / degradation have been found in several aggressive cancers ( Belle et al . , 2015 ; Boulay et al . , 2016 ) . This latter mechanism largely relies on the overexpression and amplification of genes that are involved in RTKs endocytosis and recycling , including several GTPases belonging to the Rab family which control vesicular trafficking ( Caswell et al . , 2007 ; Cheng et al . , 2004 ; Frittoli et al . , 2014 ; Kajiho et al . , 2016 ; Wheeler et al . , 2015 ) . Increased expression of endocytic / recycling molecules prolongs propagation of the signal and / or re - locate RTKs and adhesive receptors at specific membrane sites , mainly involved in cancer cell invasion ( Caswell et al . , 2008 ; Eppinga et al . , 2012 ) [ also reviewed in ( Lanzetti and Di Fiore , 2017 ; Mellman and Yarden , 2013 ; Mills et al . , 2009 ; Mosesson et al . , 2008 ; Sigismund et al . , 2012 ) ] . Among these molecules , copy number gain and overexpression of the 5 ′ - inositol lipid phosphatase synaptojanin 2 ( SYNJ2 ) in breast A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . cancer provides a paradigmatic example of sustained EGFR activation by altered trafficking pathways . Elevation of SYNJ2 promotes EGFR recycling at lamellipodia , stimulating cell motility and the formation of invadopodia ( Ben - Chetrit et al . , 2015 ) . 2 . Non - canonical kinase - dependent and - independent EGFR functions In this Section , we will discuss both kinase - dependent and - independent functions of the EGFR that have recently emerged and that diverge from the canonical EGFR signaling pathway . For what concerns kinase - independent roles , their existence has been known for many years . Indeed , while EGFR knockout ( KO ) mice are mid - gestation or perinatal lethal ( depending on the genetic background ) , due to gross developmental defects ( Miettinen et al . , 1995 ; Sibilia and Wagner , 1995 ; Threadgill et al . , 1995 ) , kinase - dead EGFR knock - in ( KI ) mice are viable , displaying only mild defects in the eye and skin ( Luetteke et al . , 1994 ) . In addition , the EGFR is able to promote cell survival pathways through both kinase dependent and independent mechanisms ( Ewald et al . , 2003 ; Tan et al . , 2016a ) . These EGFR kinase - independent functions could result from the heterodimerization of the EGFR with other ErbB family members or could be mediated by kinases that crosstalk with the EGFR pathway ( e . g . Src or p38 - MAPK , see Section 2 . 2 ) . Moreover , inactivation of phosphatases ( e . g . PTP1B , see Section 2 . 1 and 2 . 2 ) might contribute to activation of EGFR signaling . More work is needed to address whether these mechanisms are at play in living cells and if they are mutually exclusive or co - existing in the regulation EGFR function . 2 . 1 . ER contact sites regulate EGFR signaling at different steps of the endocytic pathway Communication between organelles is critical for several fundamental cellular processes , including organelle positioning and function , organelle fission , lipid transport and Ca 2 + signaling ( Phillips and Voeltz , 2016 ; Saheki and De Camilli , 2017 ; van Bergeijk et al . , 2016 ) . Communication occurs through so - called ‘contact sites’ : regions of juxtaposition ( ≤ 20 nm ) between two heterologous A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . membranes , tethered by in trans protein - protein interactions ( Eisenberg - Bord et al . , 2016 ; Phillips and Voeltz , 2016 ) . In particular , the ER , due to its tubular organization that extends all over the cell , has been shown to make contact and to exchange materials with all of the other cellular organelles ( Phillips and Voeltz , 2016 ) . ER contact sites have a critical role in controlling EGFR signaling and trafficking at multiple steps . During the initial phase of endocytosis , high doses of EGF are able to induce tubulation of cortical ER and the formation of ER contact sites with the PM , at regions where the EGFR is internalizing via NCE ( Caldieri et al . , 2017 ) ( Figure 2 ) . The formation of these contact sites is critical to induce local Ca 2 + signaling at ER - PM interface , which is in turn required for the fission of NCE tubular intermediates and , thus , for completion of the internalization process ( Caldieri et al . , 2017 ) . This mechanism ultimately leads to EGFR endocytosis via NCE , receptor degradation and signal termination ( Caldieri et al . , 2017 ; Sigismund et al . , 2008 ) . Polarized Ca 2 + waves might also be critical in specifying the final EGFR - NCE signaling output , given the role of Ca 2 + in growth factor induced cell migration ( Tsai et al . , 2014 ) , an issue that requires further investigation . All along the endocytic route , the ER makes contact with the endosomes and these contact sites increase as endosomes traffic and mature ( Friedman et al . , 2013 ) . ER - endosomal contact sites are critical in defining the timing and position of endosome fission during cargo sorting ( Rowland et al . , 2014 ) , but they also have a direct role in the regulation of EGFR signaling . Indeed , a major RTK phosphatase , PTP1B , localizes to the cytosolic face of the ER and dephosphorylates the EGFR in trans during its trafficking to the endosomes / MVBs ( Eden et al . , 2010 ; Haj et al . , 2002 ) . Of note , PTP1B regulates both constitutively internalized EGFR , thereby restricting spurious EGFR kinase activation , as well as ligand - activated receptor that is dephosphorylated by PTP1B on the way to the lysosome ( Baumdick et al . , 2015 ) . The formation of ER - MVB contact sites is mediated by annexin - 1 and is Ca 2 + - dependent ( Eden et al . , 2016 ; Kilpatrick et al . , 2017 ) . The release of Ca 2 + occurs through the two - pore channel ( TPC ) that is localized on the endo - lysosomal membrane at ER contact sites ( Kilpatrick et al . , 2017 ) . Disrupting these contact sites has been shown to delay PTP1B - mediated A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . EGFR dephosphorylation , causing delayed receptor degradation and enhanced signaling ( Eden et al . , 2016 ; Kilpatrick et al . , 2017 ) . 2 . 2 . Stress - induced EGFR trafficking pathways Different stresses applied to cells have been shown to stimulate EGFR endocytosis and trafficking in a ligand - independent fashion . For instance , UV radiation , cisplatin , inflammatory cytokines ( TNF  and the antibiotic anisomycin , all trigger p38 - MAPK activation , required for ligand - independent EGFR internalization [ reviewed in ( Tan et al . , 2016a ; Tomas et al . , 2014 ) ] . While the mechanism is similar for all these treatments , it has been most extensively characterized in the case of UV treatment . UV - stimulated EGFR endocytosis occurs via CME and depends on the phosphorylation of serine / threonine residues in the C - terminal receptor tail mediated by p38 - MAPK activity ( Oksvold et al . , 2004 ; Tomas et al . , 2017 ; Tong et al . , 2014 ; Vergarajauregui et al . , 2006 ; Zwang and Yarden , 2006 ) . Interestingly , other receptors , such as the Insulin receptor , c - MET and the transferrin receptor ( TfR ) , are not internalized upon UV treatment , suggesting the existence of some level of specificity ( Zwang and Yarden , 2006 ) . Once internalized , EGFRs accumulate in a subpopulation of MVBs , distinct from the EGF - induced MVB pool , where they are entrapped into intraluminal vesicles ( ILVs ) without being degraded ( Oksvold et al . , 2002 ; Tomas et al . , 2015 ) . The process is reversible since , upon p38 - MAPK inhibition , ILV - localized EGFRs can be recovered to the limiting MVB membrane from which they are recycled back to the PM ( Tomas et al . , 2015 ) . EGFR also responds to hypoxia , which , on the one hand , upregulates the transcription of the EGFR gene , providing a mechanism for EGFR overexpression in absence of genetic alterations ( Franovic et al . , 2007 ) ; on the other hand , it triggers EGFR Src - dependent , caveolae - dependent endocytosis ( Shen et al . , 2013 ) . At endosomes , EGFRs bind and phosphorylate the endosomal membrane - associated protein , argonaute 2 ( AGO2 ) , a molecule involved in micro - RNA ( miRNA ) maturation , causing inhibition of the maturation of tumor suppressor miRNAs , thus promoting cancer A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . cell survival ( Shen et al . , 2013 ) . A similar mechanism of EGFR internalization and endosomal accumulation appears to be at work also in the case of oxidative stress induced by H 2 O 2 ( Filosto et al . , 2011 ; Khan et al . , 2006 ; Ravid et al . , 2002 ) . In this case , the generation of reactive oxygen species inactivates redox - sensitive , cysteine - based , tyrosine phosphatases , including PTP1B , causing the activation of Src and , possibly , of the EGFR itself ( Denu and Tanner , 1998 ; Lee et al . , 1998 ) . Src - dependent caveolae - mediated EGFR endocytosis is also activated by ionizing radiation . Importantly , mechanisms of resistance to ionizing radiation depend on the EGFR ( Dittmann et al . , 2008 ) . Indeed , this treatment increases EGFR expression , induces Src activation and caveolae - mediated EGFR endocytosis . Phosphorylation of threonine 654 in the EGFR juxtamembrane region by PKC  negatively regulates Cbl - dependent ubiquitination and promotes EGFR nuclear translocation , leading to enhanced DNA repair and cell survival ( Dittmann et al . , 2008 ; Wanner et al . , 2008 ) . In agreement , EGFR nuclear localization has been associated with radiation resistance and poor clinical outcome [ ( Tan et al . , 2016a ; Tomas et al . , 2014 ) . In conclusion , it is emerging that multiple mechanisms of ligand - independent trafficking are activated under stress conditions and that these mechanisms can promote cancer cell survival . However , more work is needed to molecularly dissect these pathways , in order to clarify how they are regulated , how they interplay with the canonical EGFR pathway , and , whether they can be hijacked to prevent resistance to anti - EGFR therapies . 2 . 3 . Role of EGFR in autophagy Autophagy is critical in maintaining cellular homeostasis and is finely regulated under physiological conditions to allow cells to rapidly respond to environmental changes . It is deregulated in different pathologies , including neurodegenerative diseases , aging and cancer , and is one of the major mechanisms promoting resistance to cancer therapies [ for recent reviews see , for instance ( Galluzzi et al . , 2017 ; Galluzzi et al . , 2015 ; Goldsmith et al . , 2014 ; Menzies et al . , 2015 ; Rubinsztein et al . , 2012 ) ] . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . The EGFR is a crucial regulator of autophagy . In nutrient - rich growth conditions , ligand - activated EGFR has a dual activity : on the one hand , it stimulates cell proliferation ; on the other , it inhibits autophagy . Inhibition of autophagy is achieved : i ) directly , through the phosphorylation and consequent inhibition of Beclin - 1 , a core subunit of the VPS34 / autophagy - initiation complex ( Wei et al . , 2013 ) ; and ii ) indirectly , through the activation of AKT . In turn , AKT activates the mechanistic target of the rapamycin complex 1 ( mTORC1 ) pathway , which ultimately inhibits autophagy ( Tan et al . , 2016a ) . In contrast , under serum - starved conditions , inactive EGFR is emerging as a promoter of autophagy . In this case , ligand - unbound receptors , which constitutively traffic towards the endosomes , are sequestered by the lysosomal - associated protein transmembrane 4 beta ( LAPTM4B ) , localized in a subpopulation of early and late endosomes . The increased EGFR endosomal pool interacts with the autophagy inhibitor , Rubicon , causing its dissociation from Beclin - 1 , leading to Beclin - 1 activation and autophagy initiation ( Tan et al . , 2015a ; Tan et al . , 2015b ) ( Figure 2 ) . This function is maintained by the kinase - dead EGFR mutant , confirming that it is indeed independent of kinase activation ( Tan et al . , 2015b ) . The loss of EGFR generates cells defective in autophagy initiation , at variance with the loss of other RTKs , including c - MET , PDGFR and FGFR2 ( Tan et al . , 2015b ) , suggesting that this is an EGFR - specific function . Autophagy initiation seems to occur at ER - endosome contact sites . In particular , to initiate autophagy , ATG14 on the ER surface has to interact with PIPKI  i5 kinase ( PIPKI  i5K ) , an enzyme localized on endosomal membranes in complex with inactive EGFR and LAPTM4B . This binding stimulates phosphatidylinositol 4 , 5 - bisphosphate ( PIP 2 ) production by PIPKI  i5 and autophagy ( Tan et al . , 2016b ) . Thus , ER contact sites seem to provide a platform for autophagic complex assembly . Interestingly , the ER - resident protein RTN3 , which is required for the establishment of ER - PM contact sites needed for EGFR endocytosis via NCE ( Caldieri et al . , 2017 ) , has also been implicated in ER turnover by selective autophagy ( Grumati et al . , 2017 ) . A specific RTN3 isoform , which possesses multiple LC3 - interacting regions ( LIRs ) , has been found to exert this function ( Grumati et A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . al . , 2017 ) . Whether these two functions of RTN3 are related , and how they are integrated within the cell , is not yet known , however , they might unveil connections between ligand - dependent and - independent EGFR trafficking pathways . Activation of autophagy has been found to promote resistance and survival of cancer cells treated with EGFR kinase inhibitors ( Tan et al . , 2016b ) . The mechanism seems to resemble the one induced by LAPTM4B in the physiological context . Indeed , these compounds promote endosomal accumulation of the EGFR , enhancing its association with Rubicon and favoring the dissociation of Rubicon / Beclin - 1 complex , thereby , initiating the autophagic flux ( Tan et al . , 2015a ) . It is possible that other stresses causing EGFR endosomal accumulation ( discussed in Section 2 . 2 ) might also activate autophagy as a part of their survival response , a scenario that deserves further investigation . 2 . 4 . Mitochondrial functions of EGFR The EGFR is usually considered to act at the PM and on vesicles mainly belonging to the endosomal compartment . However , it also localizes to the nucleus and mitochondria . Translocation of full - length EGFR into the nucleus has long been documented and the functions it has at this location have been extensively investigated ; we , therefore , refer the readers to detailed reviews ( Brand et al . , 2011 ; Han and Lo , 2012 ) . Differently , the role of EGFR in mitochondria is more elusive and has been connected with anti - apoptotic and metabolic functions . In NSCLC cells , high levels of EGFR expression have been detected in the mitochondria ( Che et al . , 2015 ) . In these cells , artificially mitochondria - targeted EGFR redistributes these organelles to lamellipodia , increasing cell motility , possibly through the localized increase of energy ( Che et al . , 2015 ) . In addition , translocation of wild - type EGFR and of the EGFRvIII mutant into mitochondria has also been observed in cells treated with kinase inhibitors , or following pro - apoptotic stimuli ( Cao et al . , 2011 ) . This translocation correlates with resistance to apoptosis and decreased sensitivity to EGFR inhibition ( Cao et al . , 2011 ) . The latter function might be related to the ability of both wild - A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . type EGFR and EGFRvIII to constitutively bind to p53 - upregulated modulator of apoptosis ( PUMA ) , a pro - apoptotic member of the Bcl - 2 family of proteins primarily located in the mitochondria ( Zhu et al . , 2010 ) . In breast cancer cells , translocation of EGFR to mitochondria has been shown to occur upon EGF stimulation resulting in phosphorylation of the cytochrome c oxidase subunit II ( Boerner et al . , 2004 ; Demory et al . , 2009 ) . The biological outcome of this modification is not clear . However , this event requires phosphorylation of the EGFR on tyrosine 845 by Src , which also undergoes mitochondrial translocation with similar kinetics to that of the EGFR ( Demory et al . , 2009 ) . Of note , EGF stimulation also induces palmitoylation of mitochondrial EGFR , which , in turn , favors fusion of mitochondria ( Bollu et al . , 2014 ) . EGFR , independently of its kinase activity , interacts with the fatty acid , synthase , stimulating de novo synthesis of palmitate ( Bollu et al . , 2014 ) . This finding points to the involvement of the EGFR in the regulation of cell metabolism , and supports the existence of a signaling - metabolic wiring that plays a critical role in cancer . 2 . 5 . Role of EGFR in cancer cell metabolism Oncogenic signaling pathways induce metabolic reprogramming in cancer cells supporting tumor growth ( Cairns et al . , 2011 ) . In this context , EGFR signaling has been involved in the regulation of several metabolic processes that are critical for cancer cell proliferation : from the biosynthesis of fatty acids and pyrimidines , to glucose catabolism ( Guo et al . , 2009 ; Makinoshima et al . , 2014 ) . The EGFR promotes these metabolic pathways both directly , by phosphorylating rate - limiting enzymes ( Lim et al . , 2016 ; Zhang et al . , 2017 ) , or indirectly through activation of the MYC transcription factor and of the AKT signaling cascade [ ( Babic et al . , 2013 ; Guo et al . , 2009 ; Makinoshima et al . , 2014 ; Makinoshima et al . , 2015 ) and reviewed in ( DeBerardinis and Chandel , 2016 ; Masui et al . , 2014 ) ] . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . In glioblastoma multiforme , oncogenic EGFR signaling by EGFRvIII stimulates the PI3K / AKT - dependent nuclear translocation of sterol regulatory element - binding protein 1 ( SREBP - 1 ) and the expression of the low - density lipoprotein receptor ( LDLR ) . Increased LDLR , in turn , allows for the uptake of cholesterol bypassing negative feedback regulation ( Guo et al . , 2009 ) . This represents a point of metabolic vulnerability as these cells depend on cholesterol uptake and are highly sensitive to inhibitors of fatty acid and cholesterol biosynthesis ( Guo et al . , 2011 ) . Furthermore , the EGFR has been recently found to directly phosphorylate and , thereby , stabilize stearoyl - CoA desaturase - 1 ( SCD1 ) , resulting in the upregulation of monounsaturated fatty acid production ( Zhang et al . , 2017 ) . Notably , phosphorylation of SDC1 correlates with poor prognosis of glioblastoma multiforme ( Zhang et al . , 2017 ) , suggesting that it might have a causative role in these tumors . One of the best - studied metabolic drifts in cancer cells is the elevation of glycolysis in presence of oxygen : the Warburg effect . Cancer cells are generally characterized by the avid uptake of glucose , which occurs through increased expression and membrane localization of glucose transporters , mainly GLUT1 and GLUT3 ( Barron et al . , 2016 ) . Intracellular glucose is metabolized to pyruvate that , in cancer cells , is preferentially converted into lactate ( Cairns et al . , 2011 ) . The EGFR has been shown to foster aerobic glycolysis through several , both kinase - dependent and - independent , mechanisms ( Figure 2 ) . Physical association of EGFR with GLUT1 stabilizes the transporter at the cell surface increasing the glucose influx ( Weihua et al . , 2008 ) . This kinase - independent function provides survival advantages to cells , helping them escape autophagic cell death when grown in the presence of low glucose concentrations ( Weihua et al . , 2008 ) . In response to EGF stimulation , the EGFR controls expression of hexokinase ( HK1 ) and phosphorylation of the pyruvate kinase M2 ( PKM2 ) , two glycolytic enzymes that catalyze key steps in the pathway , thus increasing aerobic glycolysis of breast cancer cells ( Lim et al . , 2016 ) . One A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . relevant “side effect” of increased aerobic glycolysis is the production of high levels of lactate that , in these tumors , inhibits the cytotoxic activity of T - cells , supporting their immune escape ( Lim et al . , 2016 ) . In lung adenocarcinoma cells bearing oncogenic EGFR mutations , deregulated signaling has been shown to stabilize GLUT1 at the cell surface through the activation of the PI3K / AKT / mTOR pathway ( Makinoshima et al . , 2015 ) . Indeed , activation of AKT in response to cytokine stimulation has long been known to inhibit endocytosis of GLUT1 in lymphoid cells ( Wieman et al . , 2007 ; Wofford et al . , 2008 ) . Recent findings showing that AKT phosphorylates and inhibits thioredoxin - interacting protein ( TXNIP ) , the endocytic adaptor responsible for clathrin - mediated endocytosis of GLUT1 ( Hong et al . , 2016 ; Waldhart et al . , 2017 ) , suggest that this might be the mechanism at work . Of note , inhibition of the PI3K / AKT / mTOR pathway in lung cancer cells harboring EGFR mutations , affects the glycolytic flux impairing their viability ( Makinoshima et al . , 2015 ) . In line with these findings , combined inhibition of EGFR and glycolysis has been shown to synergistically suppress proliferation of triple - negative breast cancer cells ( Lim et al . , 2016 ) , further supporting the relevance of EGFR signaling in cancer cell metabolism . 2 . 6 . Membrane trafficking influences the efficacy of EGFR - targeted therapies Given its critical role in cancer , several EGFR - targeted therapies have been developed , including monoclonal humanized antibodies ( mAbs ) directed against the receptor extracellular domain , as well selective small molecule inhibitors targeting the tyrosine kinase domain . Small molecule EGFR inhibitors ( e . g . , Gefinitib , Erlotinib and Afatinib ) have been approved for lung cancer treatment as a first - line therapy in those cases where EGFR mutations have been confirmed ( Cohen et al . , 2005 ; Hirsch et al . , 2013 ; Thatcher et al . , 2005 ) . Interestingly , in addition to kinase inhibition , Gefitinib was shown to increase the formation of inactive EGFR dimers through some form of communication between the kinase domain and the extracellular dimerization domain , suggesting the possibility that A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Gefitinib - induced dimers could be more rapidly endocytosed and degraded ( Arteaga et al . , 1997 ; Gan et al . , 2007 ) , an issue that warrants further studies . Cetuximab and Panitumumab are the most widely employed EGFR - neutralizing monoclonal antibodies , used for the treatment of head and neck cancer and metastatic colon cancer ( Licitra et al . , 2013 ; Peeters et al . , 2015 ; Pierotti et al . , 2010 ) . Mechanistically , these compounds act by preventing ligand binding , thereby , inhibiting receptor activation and downstream signaling ( Bou - Assaly and Mukherji , 2010 ; Dubois and Cohen , 2009 ; Vincenzi et al . , 2008 ) . They also favor EGFR dimerization , which , in turn , causes internalization of antibody - bound dimers . These complexes are internalized at a lower rate and are more efficiently recycled to the PM compared with EGF - bound dimers ( Jaramillo et al . , 2006 ) . The combined use of anti - EGFR antibodies directed against non - overlapping antigens appears to be a more efficient strategy than the use of single antibodies , as it increases EGFR endocytosis and degradation ( Ferraro et al . , 2013 ; Friedman et al . , 2005 ; Pedersen et al . , 2010 ) , raising the possibility of improving anti - tumor efficacy through the regulation of EGFR trafficking . Currently , however , both EGFR antibody - based therapies , as well as small molecule inhibitors , have been shown to exert a limited response and to frequently evoke resistance in patients due to : i ) secondary mutations within the EGFR itself ( e . g . , T790M in NSCLC , and mutations found in the extracellular domain of cetuximab - resistant colorectal cancers , Figure 1B ) , ii ) alterations in other kinases ( e . g . , c - MET , PIK3CA , BRAF , MAPK1 ) , or iii ) the emergence of feedback regulatory loops and mechanisms that overcome EGFR kinase inhibition [ reviewed in ( Mancini and Yarden , 2016 ) ] . In the latter case , the effect of therapies might be dampened by the activation of ligand - independent EGFR trafficking pathways and functions , such as increased autophagy and elevated aerobic glycolysis ( discussed in Section 2 . 3 and 2 . 5 ) . In addition , mechanisms that likely contribute to the emergence of drug resistance include also : i ) re - localization of the EGFR to the nucleus following ionizing irradiation to promote DNA repair ( Liccardi et al . , 2011 ; Szumiel , 2006 ) , and ii ) translocation to mitochondria upon kinase inhibitor treatment to exert anti - apoptotic effects ( Cao et al . , 2011 ) ( detailed in Section 2 . 4 ) . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Concluding remarks The EGFR has long been considered the prototype of all RTKs . Indeed , most of the knowledge accumulated on signal transduction cascades in general and on the mechanisms underlying receptor endocytosis , recycling and degradation has derived from studies focused on the EGFR . Nevertheless , novel unexpected functions of this receptor continue to emerge , some of which are linked to previously unrecognized subcellular localizations . Thus , despite the large body of knowledge already accumulated , this receptor still holds a number of surprises . An emerging aspect that could be exploited for cancer treatment is the study of how membrane trafficking can influence the outcome of EGFR - targeted therapies . Findings in this area could increase efficacy and overcome or delay the occurrence of resistance to treatments , an adverse event that invariably occurs in the patient population . Recently , in an attempt to overcome tumor resistance , simultaneous targeting of driver mutations and basic cellular processes has been proposed as a promising therapeutic perspective ( Nagel et al . , 2016 ) . In this framework , endocytosis / recycling , autophagy and metabolism might represent targets for the development of inhibitory tools to be tested in combination with EGFR inhibitors ( Mellman and Yarden , 2013 ) . A similar approach is currently being undertaken in tumors where the oncogenic EGFR signaling promotes metabolic reprogramming with promising results . Acknowledgments We thank Rosalind Gunby for critically reading the manuscript . This work was supported by grants from WWCR ( Worldwide Cancer Research ) to SS ( 16 - 1245 ) , the Associazione Italiana per la Ricerca sul Cancro ( AIRC ) Investigator Grant , project 15180 to L . L . and Fondo Ricerca Locale 2017 ( University of Turin ) to LL . All authors declare no conflicts of interest . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . References Aguet , F . , Antonescu , C . N . , Mettlen , M . , Schmid , S . L . , Danuser , G . , 2013 . Advances in analysis of low signal - to - noise images link dynamin and AP2 to the functions of an endocytic checkpoint . Dev Cell 26 , 279 - 291 . Arena , S . , Bellosillo , B . , Siravegna , G . , Martínez , A . , Cañadas , I . , Lazzari , L . , Ferruz , N . , Russo , M . , Misale , S . , González , I . , Iglesias , M . , Gavilan , E . , Corti , G . , Hobor , S . , Crisafulli , G . , Salido , M . , Sánchez , J . , Dalmases , A . , Bellmunt , J . , De Fabritiis , G . , Rovira , A . , Di Nicolantonio , F . , Albanell , J . , Bardelli , A . , Montagut , C . , 2015 . Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer . Clin Cancer Res 21 , 2157 - 2166 . Arena , S . , Siravegna , G . , Mussolin , B . , Kearns , J . D . , Wolf , B . B . , Misale , S . , Lazzari , L . , Bertotti , A . , Trusolino , L . , Adjei , A . A . , Montagut , C . , Di Nicolantonio , F . , Nering , R . , Bardelli , A . , 2016 . MM - 151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations . Sci Transl Med 8 , 324ra314 . Arteaga , C . L . , Ramsey , T . T . , Shawver , L . K . , Guyer , C . A . , 1997 . Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site . The Journal of biological chemistry 272 , 23247 - 23254 . Babic , I . , Anderson , E . S . , Tanaka , K . , Guo , D . , Masui , K . , Li , B . , Zhu , S . , Gu , Y . , Villa , G . R . , Akhavan , D . , Nathanson , D . , Gini , B . , Mareninov , S . , Li , R . , Camacho , C . E . , Kurdistani , S . K . , Eskin , A . , Nelson , S . F . , Yong , W . H . , Cavenee , W . K . , Cloughesy , T . F . , Christofk , H . R . , Black , D . L . , Mischel , P . S . , 2013 . EGFR mutation - induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer . Cell Metab 17 , 1000 - 1008 . Barbieri , E . , Di Fiore , P . P . , Sigismund , S . , 2016 . Endocytic control of signaling at the plasma membrane . Curr Opin Cell Biol 39 , 21 - 27 . Barron , C . C . , Bilan , P . J . , Tsakiridis , T . , Tsiani , E . , 2016 . Facilitative glucose transporters : Implications for cancer detection , prognosis and treatment . Metabolism 65 , 124 - 139 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Baulida , J . , Kraus , M . H . , Alimandi , M . , Di Fiore , P . P . , Carpenter , G . , 1996 . All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired . J Biol Chem 271 , 5251 - 5257 . Baumdick , M . , Bruggemann , Y . , Schmick , M . , Xouri , G . , Sabet , O . , Davis , L . , Chin , J . W . , Bastiaens , P . I . , 2015 . EGF - dependent re - routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling . eLife 4 . Belle , L . , Ali , N . , Lonic , A . , Li , X . , Paltridge , J . L . , Roslan , S . , Herrmann , D . , Conway , J . R . , Gehling , F . K . , Bert , A . G . , Crocker , L . A . , Tsykin , A . , Farshid , G . , Goodall , G . J . , Timpson , P . , Daly , R . J . , Khew - Goodall , Y . , 2015 . The tyrosine phosphatase PTPN14 ( Pez ) inhibits metastasis by altering protein trafficking . Sci Signal 8 , ra18 . Ben - Chetrit , N . , Chetrit , D . , Russell , R . , Körner , C . , Mancini , M . , Abdul - Hai , A . , Itkin , T . , Carvalho , S . , Cohen - Dvashi , H . , Koestler , W . J . , Shukla , K . , Lindzen , M . , Kedmi , M . , Lauriola , M . , Shulman , Z . , Barr , H . , Seger , D . , Ferraro , D . A . , Pareja , F . , Gil - Henn , H . , Lapidot , T . , Alon , R . , Milanezi , F . , Symons , M . , Ben - Hamo , R . , Efroni , S . , Schmitt , F . , Wiemann , S . , Caldas , C . , Ehrlich , M . , Yarden , Y . , 2015 . Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer . Sci Signal 8 , ra7 . Bergeron , J . J . , Di Guglielmo , G . M . , Dahan , S . , Dominguez , M . , Posner , B . I . , 2016 . Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction . Annu Rev Biochem 85 , 573 - 597 . Bisi , S . , Disanza , A . , Malinverno , C . , Frittoli , E . , Palamidessi , A . , Scita , G . , 2013 . Membrane and actin dynamics interplay at lamellipodia leading edge . Curr Opin Cell Biol 25 , 565 - 573 . Boerner , J . L . , Demory , M . L . , Silva , C . , Parsons , S . J . , 2004 . Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II . Mol Cell Biol 24 , 7059 - 7071 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Bollu , L . R . , Ren , J . , Blessing , A . M . , Katreddy , R . R . , Gao , G . , Xu , L . , Wang , J . , Su , F . , Weihua , Z . , 2014 . Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells . Cell Cycle 13 , 2415 - 2430 . Bou - Assaly , W . , Mukherji , S . , 2010 . Cetuximab ( erbitux ) . AJNR . American journal of neuroradiology 31 , 626 - 627 . Boucrot , E . , Ferreira , A . P . , Almeida - Souza , L . , Debard , S . , Vallis , Y . , Howard , G . , Bertot , L . , Sauvonnet , N . , McMahon , H . T . , 2015 . Endophilin marks and controls a clathrin - independent endocytic pathway . Nature 517 , 460 - 465 . Boulay , P . L . , Mitchell , L . , Turpin , J . , Huot - Marchand , J . , Lavoie , C . , Sanguin - Gendreau , V . , Jones , L . , Mitra , S . , Livingstone , J . M . , Campbell , S . , Hallett , M . , Mills , G . B . , Park , M . , Chodosh , L . , Strathdee , D . , Norman , J . C . , Muller , W . J . , 2016 . Rab11 - FIP1C Is a Critical Negative Regulator in ErbB2 - Mediated Mammary Tumor Progression . Cancer Res 76 , 2662 - 2674 . Brand , T . M . , Iida , M . , Li , C . , Wheeler , D . L . , 2011 . The nuclear epidermal growth factor receptor signaling network and its role in cancer . Discov Med 12 , 419 - 432 . Cairns , R . A . , Harris , I . S . , Mak , T . W . , 2011 . Regulation of cancer cell metabolism . Nat Rev Cancer 11 , 85 - 95 . Caldieri , G . , Barbieri , E . , Nappo , G . , Raimondi , A . , Bonora , M . , Conte , A . , Verhoef , L . , Confalonieri , S . , Malabarba , M . G . , Bianchi , F . , Cuomo , A . , Bonaldi , T . , Martini , E . , Mazza , D . , Pinton , P . , Tacchetti , C . , Polo , S . , Di Fiore , P . P . , Sigismund , S . , 2017 . Reticulon 3 - dependent ER - PM contact sites control EGFR nonclathrin endocytosis . Science 356 , 617 - 624 . Cao , X . , Zhu , H . , Ali - Osman , F . , Lo , H . W . , 2011 . EGFR and EGFRvIII undergo stress - and EGFR kinase inhibitor - induced mitochondrial translocalization : a potential mechanism of EGFR - driven antagonism of apoptosis . Mol Cancer 10 , 26 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Capuani , F . , Conte , A . , Argenzio , E . , Marchetti , L . , Priami , C . , Polo , S . , Di Fiore , P . P . , Sigismund , S . , Ciliberto , A . , 2015 . Quantitative analysis reveals how EGFR activation and downregulation are coupled in normal but not in cancer cells . Nature communications 6 , 7999 . Carpentier , J . L . , Gorden , P . , Anderson , R . G . , Goldstein , J . L . , Brown , M . S . , Cohen , S . , Orci , L . , 1982 . Co - localization of 125I - epidermal growth factor and ferritin - low density lipoprotein in coated pits : a quantitative electron microscopic study in normal and mutant human fibroblasts . The Journal of cell biology 95 , 73 - 77 . Caswell , P . T . , Chan , M . , Lindsay , A . J . , McCaffrey , M . W . , Boettiger , D . , Norman , J . C . , 2008 . Rab - coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments . J Cell Biol 183 , 143 - 155 . Caswell , P . T . , Spence , H . J . , Parsons , M . , White , D . P . , Clark , K . , Cheng , K . W . , Mills , G . B . , Humphries , M . J . , Messent , A . J . , Anderson , K . I . , McCaffrey , M . W . , Ozanne , B . W . , Norman , J . C . , 2007 . Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments . Dev Cell 13 , 496 - 510 . Che , T . F . , Lin , C . W . , Wu , Y . Y . , Chen , Y . J . , Han , C . L . , Chang , Y . L . , Wu , C . T . , Hsiao , T . H . , Hong , T . M . , Yang , P . C . , 2015 . Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC . Oncotarget 6 , 37349 - 37366 . Chen , P . H . , Bendris , N . , Hsiao , Y . J . , Reis , C . R . , Mettlen , M . , Chen , H . Y . , Yu , S . L . , Schmid , S . L . , 2017 . Crosstalk between CLCb / Dyn1 - Mediated Adaptive Clathrin - Mediated Endocytosis and Epidermal Growth Factor Receptor Signaling Increases Metastasis . Dev Cell 40 , 278 - 288 e275 . Cheng , K . W . , Lahad , J . P . , Kuo , W . L . , Lapuk , A . , Yamada , K . , Auersperg , N . , Liu , J . , Smith - McCune , K . , Lu , K . H . , Fishman , D . , Gray , J . W . , Mills , G . B . , 2004 . The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers . Nat Med 10 , 1251 - 1256 . Chung , I . , Akita , R . , Vandlen , R . , Toomre , D . , Schlessinger , J . , Mellman , I . , 2010 . Spatial control of EGF receptor activation by reversible dimerization on living cells . Nature 464 , 783 - 787 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Cohen , M . H . , Johnson , J . R . , Chen , Y . F . , Sridhara , R . , Pazdur , R . , 2005 . FDA drug approval summary : erlotinib ( Tarceva ) tablets . Oncologist 10 , 461 - 466 . Conte , A . , Sigismund , S . , 2016 . Chapter Six - The Ubiquitin Network in the Control of EGFR Endocytosis and Signaling . Progress in molecular biology and translational science 141 , 225 - 276 . DeBerardinis , R . J . , Chandel , N . S . , 2016 . Fundamentals of cancer metabolism . Sci Adv 2 , e1600200 . Demory , M . L . , Boerner , J . L . , Davidson , R . , Faust , W . , Miyake , T . , Lee , I . , Hüttemann , M . , Douglas , R . , Haddad , G . , Parsons , S . J . , 2009 . Epidermal growth factor receptor translocation to the mitochondria : regulation and effect . J Biol Chem 284 , 36592 - 36604 . Denu , J . M . , Tanner , K . G . , 1998 . Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide : evidence for a sulfenic acid intermediate and implications for redox regulation . Biochemistry 37 , 5633 - 5642 . Dittmann , K . , Mayer , C . , Kehlbach , R . , Rodemann , H . P . , 2008 . Radiation - induced caveolin - 1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA - PK . Mol Cancer 7 , 69 . Dubois , E . A . , Cohen , A . F . , 2009 . Panitumumab . Br J Clin Pharmacol 68 , 482 - 483 . Eden , E . R . , Sanchez - Heras , E . , Tsapara , A . , Sobota , A . , Levine , T . P . , Futter , C . E . , 2016 . Annexin A1 Tethers Membrane Contact Sites that Mediate ER to Endosome Cholesterol Transport . Developmental cell 37 , 473 - 483 . Eden , E . R . , White , I . J . , Tsapara , A . , Futter , C . E . , 2010 . Membrane contacts between endosomes and ER provide sites for PTP1B - epidermal growth factor receptor interaction . Nature cell biology 12 , 267 - 272 . Eisenberg - Bord , M . , Shai , N . , Schuldiner , M . , Bohnert , M . , 2016 . A Tether Is a Tether Is a Tether : Tethering at Membrane Contact Sites . Dev Cell 39 , 395 - 409 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Eppinga , R . D . , Krueger , E . W . , Weller , S . G . , Zhang , L . , Cao , H . , McNiven , M . A . , 2012 . Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma . Oncogene 31 , 1228 - 1241 . Ewald , J . A . , Wilkinson , J . C . , Guyer , C . A . , Staros , J . V . , 2003 . Ligand - and kinase activity - independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells . Exp Cell Res 282 , 121 - 131 . Ferraro , D . A . , Gaborit , N . , Maron , R . , Cohen - Dvashi , H . , Porat , Z . , Pareja , F . , Lavi , S . , Lindzen , M . , Ben - Chetrit , N . , Sela , M . , Yarden , Y . , 2013 . Inhibition of triple - negative breast cancer models by combinations of antibodies to EGFR . Proc Natl Acad Sci U S A 110 , 1815 - 1820 . Filosto , S . , Khan , E . M . , Tognon , E . , Becker , C . , Ashfaq , M . , Ravid , T . , Goldkorn , T . , 2011 . EGF receptor exposed to oxidative stress acquires abnormal phosphorylation and aberrant activated conformation that impairs canonical dimerization . PLoS One 6 , e23240 . Franovic , A . , Gunaratnam , L . , Smith , K . , Robert , I . , Patten , D . , Lee , S . , 2007 . Translational up - regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer . Proc Natl Acad Sci U S A 104 , 13092 - 13097 . Freed , D . M . , Bessman , N . J . , Kiyatkin , A . , Salazar - Cavazos , E . , Byrne , P . O . , Moore , J . O . , Valley , C . C . , Ferguson , K . M . , Leahy , D . J . , Lidke , D . S . , Lemmon , M . A . , 2017 . EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics . Cell . French , A . R . , Sudlow , G . P . , Wiley , H . S . , Lauffenburger , D . A . , 1994 . Postendocytic trafficking of epidermal growth factor - receptor complexes is mediated through saturable and specific endosomal interactions . The Journal of biological chemistry 269 , 15749 - 15755 . Friedman , J . R . , Dibenedetto , J . R . , West , M . , Rowland , A . A . , Voeltz , G . K . , 2013 . Endoplasmic reticulum - endosome contact increases as endosomes traffic and mature . Molecular biology of the cell 24 , 1030 - 1040 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Friedman , L . M . , Rinon , A . , Schechter , B . , Lyass , L . , Lavi , S . , Bacus , S . S . , Sela , M . , Yarden , Y . , 2005 . Synergistic down - regulation of receptor tyrosine kinases by combinations of mAbs : implications for cancer immunotherapy . Proceedings of the National Academy of Sciences of the United States of America 102 , 1915 - 1920 . Frittoli , E . , Palamidessi , A . , Marighetti , P . , Confalonieri , S . , Bianchi , F . , Malinverno , C . , Mazzarol , G . , Viale , G . , Martin - Padura , I . , Garré , M . , Parazzoli , D . , Mattei , V . , Cortellino , S . , Bertalot , G . , Di Fiore , P . P . , Scita , G . , 2014 . A RAB5 / RAB4 recycling circuitry induces a proteolytic invasive program and promotes tumor dissemination . J Cell Biol 206 , 307 - 328 . Galluzzi , L . , Baehrecke , E . H . , Ballabio , A . , Boya , P . , Bravo - San Pedro , J . M . , Cecconi , F . , Choi , A . M . , Chu , C . T . , Codogno , P . , Colombo , M . I . , Cuervo , A . M . , Debnath , J . , Deretic , V . , Dikic , I . , Eskelinen , E . L . , Fimia , G . M . , Fulda , S . , Gewirtz , D . A . , Green , D . R . , Hansen , M . , Harper , J . W . , Jaattela , M . , Johansen , T . , Juhasz , G . , Kimmelman , A . C . , Kraft , C . , Ktistakis , N . T . , Kumar , S . , Levine , B . , Lopez - Otin , C . , Madeo , F . , Martens , S . , Martinez , J . , Melendez , A . , Mizushima , N . , Munz , C . , Murphy , L . O . , Penninger , J . M . , Piacentini , M . , Reggiori , F . , Rubinsztein , D . C . , Ryan , K . M . , Santambrogio , L . , Scorrano , L . , Simon , A . K . , Simon , H . U . , Simonsen , A . , Tavernarakis , N . , Tooze , S . A . , Yoshimori , T . , Yuan , J . , Yue , Z . , Zhong , Q . , Kroemer , G . , 2017 . Molecular definitions of autophagy and related processes . EMBO J 36 , 1811 - 1836 . Galluzzi , L . , Pietrocola , F . , Bravo - San Pedro , J . M . , Amaravadi , R . K . , Baehrecke , E . H . , Cecconi , F . , Codogno , P . , Debnath , J . , Gewirtz , D . A . , Karantza , V . , Kimmelman , A . , Kumar , S . , Levine , B . , Maiuri , M . C . , Martin , S . J . , Penninger , J . , Piacentini , M . , Rubinsztein , D . C . , Simon , H . U . , Simonsen , A . , Thorburn , A . M . , Velasco , G . , Ryan , K . M . , Kroemer , G . , 2015 . Autophagy in malignant transformation and cancer progression . EMBO J 34 , 856 - 880 . Gan , H . K . , Walker , F . , Burgess , A . W . , Rigopoulos , A . , Scott , A . M . , Johns , T . G . , 2007 . The epidermal growth factor receptor ( EGFR ) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers . Implications for combination therapy with monoclonal antibody 806 . The Journal of biological chemistry 282 , 2840 - 2850 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Garay , C . , Judge , G . , Lucarelli , S . , Bautista , S . , Pandey , R . , Singh , T . , Antonescu , C . N . , 2015 . Epidermal growth factor - stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis . Mol Biol Cell 26 , 3504 - 3519 . Goh , L . K . , Huang , F . , Kim , W . , Gygi , S . , Sorkin , A . , 2010 . Multiple mechanisms collectively regulate clathrin - mediated endocytosis of the epidermal growth factor receptor . The Journal of cell biology 189 , 871 - 883 . Goldsmith , J . , Levine , B . , Debnath , J . , 2014 . Autophagy and cancer metabolism . Methods Enzymol 542 , 25 - 57 . Grandal , M . V . , Zandi , R . , Pedersen , M . W . , Willumsen , B . M . , van Deurs , B . , Poulsen , H . S . , 2007 . EGFRvIII escapes down - regulation due to impaired internalization and sorting to lysosomes . Carcinogenesis 28 , 1408 - 1417 . Grumati , P . , Morozzi , G . , Holper , S . , Mari , M . , Harwardt , M . I . , Yan , R . , Muller , S . , Reggiori , F . , Heilemann , M . , Dikic , I . , 2017 . Full length RTN3 regulates turnover of tubular endoplasmic reticulum via selective autophagy . Elife 6 . Guo , D . , Prins , R . M . , Dang , J . , Kuga , D . , Iwanami , A . , Soto , H . , Lin , K . Y . , Huang , T . T . , Akhavan , D . , Hock , M . B . , Zhu , S . , Kofman , A . A . , Bensinger , S . J . , Yong , W . H . , Vinters , H . V . , Horvath , S . , Watson , A . D . , Kuhn , J . G . , Robins , H . I . , Mehta , M . P . , Wen , P . Y . , DeAngelis , L . M . , Prados , M . D . , Mellinghoff , I . K . , Cloughesy , T . F . , Mischel , P . S . , 2009 . EGFR signaling through an Akt - SREBP - 1 - dependent , rapamycin - resistant pathway sensitizes glioblastomas to antilipogenic therapy . Sci Signal 2 , ra82 . Guo , D . , Reinitz , F . , Youssef , M . , Hong , C . , Nathanson , D . , Akhavan , D . , Kuga , D . , Amzajerdi , A . N . , Soto , H . , Zhu , S . , Babic , I . , Tanaka , K . , Dang , J . , Iwanami , A . , Gini , B . , Dejesus , J . , Lisiero , D . D . , Huang , T . T . , Prins , R . M . , Wen , P . Y . , Robins , H . I . , Prados , M . D . , Deangelis , L . M . , Mellinghoff , I . K . , Mehta , M . P . , James , C . D . , Chakravarti , A . , Cloughesy , T . F . , Tontonoz , P . , Mischel , P . S . , 2011 . An A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . LXR agonist promotes glioblastoma cell death through inhibition of an EGFR / AKT / SREBP - 1 / LDLR - dependent pathway . Cancer Discov 1 , 442 - 456 . Haj , F . G . , Verveer , P . J . , Squire , A . , Neel , B . G . , Bastiaens , P . I . , 2002 . Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum . Science 295 , 1708 - 1711 . Han , W . , Lo , H . W . , 2012 . Landscape of EGFR signaling network in human cancers : biology and therapeutic response in relation to receptor subcellular locations . Cancer Lett 318 , 124 - 134 . Han , W . , Zhang , T . , Yu , H . , Foulke , J . G . , Tang , C . K . , 2006 . Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII . Cancer biology & therapy 5 , 1361 - 1368 . Hanover , J . A . , Willingham , M . C . , Pastan , I . , 1984 . Kinetics of transit of transferrin and epidermal growth factor through clathrin - coated membranes . Cell 39 , 283 - 293 . Hirsch , F . R . , Janne , P . A . , Eberhardt , W . E . , Cappuzzo , F . , Thatcher , N . , Pirker , R . , Choy , H . , Kim , E . S . , Paz - Ares , L . , Gandara , D . R . , Wu , Y . L . , Ahn , M . J . , Mitsudomi , T . , Shepherd , F . A . , Mok , T . S . , 2013 . Epidermal growth factor receptor inhibition in lung cancer : status 2012 . Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 8 , 373 - 384 . Hong , S . Y . , Yu , F . X . , Luo , Y . , Hagen , T . , 2016 . Oncogenic activation of the PI3K / Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin - interacting protein . Cell Signal 28 , 377 - 383 . Huang , F . , Kirkpatrick , D . , Jiang , X . , Gygi , S . , Sorkin , A . , 2006 . Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain . Molecular cell 21 , 737 - 748 . Ibach , J . , Radon , Y . , Gelleri , M . , Sonntag , M . H . , Brunsveld , L . , Bastiaens , P . I . , Verveer , P . J . , 2015 . Single Particle Tracking Reveals that EGFR Signaling Activity Is Amplified in Clathrin - Coated Pits . PloS one 10 , e0143162 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Imai , K . , Takaoka , A . , 2006 . Comparing antibody and small - molecule therapies for cancer . Nat Rev Cancer 6 , 714 - 727 . Jaramillo , M . L . , Leon , Z . , Grothe , S . , Paul - Roc , B . , Abulrob , A . , O ' Connor McCourt , M . , 2006 . Effect of the anti - receptor ligand - blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting . Experimental cell research 312 , 2778 - 2790 . Jiang , X . , Huang , F . , Marusyk , A . , Sorkin , A . , 2003 . Grb2 regulates internalization of EGF receptors through clathrin - coated pits . Mol Biol Cell 14 , 858 - 870 . Jutten , B . , Keulers , T . G . , Schaaf , M . B . , Savelkouls , K . , Theys , J . , Span , P . N . , Vooijs , M . A . , Bussink , J . , Rouschop , K . M . , 2013 . EGFR overexpressing cells and tumors are dependent on autophagy for growth and survival . Radiother Oncol 108 , 479 - 483 . Kadlecova , Z . , Spielman , S . J . , Loerke , D . , Mohanakrishnan , A . , Reed , D . K . , Schmid , S . L . , 2017 . Regulation of clathrin - mediated endocytosis by hierarchical allosteric activation of AP2 . J Cell Biol 216 , 167 - 179 . Kajiho , H . , Kajiho , Y . , Frittoli , E . , Confalonieri , S . , Bertalot , G . , Viale , G . , Di Fiore , P . P . , Oldani , A . , Garre , M . , Beznoussenko , G . V . , Palamidessi , A . , Vecchi , M . , Chavrier , P . , Perez , F . , Scita , G . , 2016 . RAB2A controls MT1 - MMP endocytic and E - cadherin polarized Golgi trafficking to promote invasive breast cancer programs . EMBO Rep 17 , 1061 - 1080 . Khan , E . M . , Heidinger , J . M . , Levy , M . , Lisanti , M . P . , Ravid , T . , Goldkorn , T . , 2006 . Epidermal growth factor receptor exposed to oxidative stress undergoes Src - and caveolin - 1 - dependent perinuclear trafficking . J Biol Chem 281 , 14486 - 14493 . Kilpatrick , B . S . , Eden , E . R . , Hockey , L . N . , Yates , E . , Futter , C . E . , Patel , S . , 2017 . An Endosomal NAADP - Sensitive Two - Pore Ca2 + Channel Regulates ER - Endosome Membrane Contact Sites to Control Growth Factor Signaling . Cell reports 18 , 1636 - 1645 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Kirchhausen , T . , Owen , D . , Harrison , S . C . , 2014 . Molecular structure , function , and dynamics of clathrin - mediated membrane traffic . Cold Spring Harbor perspectives in biology 6 , a016725 . Kon , S . , Kobayashi , N . , Satake , M . , 2014 . Altered trafficking of mutated growth factor receptors and their associated molecules : implication for human cancers . Cellular logistics 4 , e28461 . Kovacs , E . , Zorn , J . A . , Huang , Y . , Barros , T . , Kuriyan , J . , 2015 . A structural perspective on the regulation of the epidermal growth factor receptor . Annual review of biochemistry 84 , 739 - 764 . Lanzetti , L . , Di Fiore , P . P . , 2017 . Behind the Scenes : Endo / Exocytosis in the Acquisition of Metastatic Traits . Cancer Res . Lee , S . R . , Kwon , K . S . , Kim , S . R . , Rhee , S . G . , 1998 . Reversible inactivation of protein - tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor . J Biol Chem 273 , 15366 - 15372 . Lemmon , M . A . , Schlessinger , J . , 2010 . Cell signaling by receptor tyrosine kinases . Cell 141 , 1117 - 1134 . Lemmon , M . A . , Schlessinger , J . , Ferguson , K . M . , 2014 . The EGFR family : not so prototypical receptor tyrosine kinases . Cold Spring Harbor perspectives in biology 6 , a020768 . Lenferink , A . E . , Pinkas - Kramarski , R . , van de Poll , M . L . , van Vugt , M . J . , Klapper , L . N . , Tzahar , E . , Waterman , H . , Sela , M . , van Zoelen , E . J . , Yarden , Y . , 1998 . Differential endocytic routing of homo - and hetero - dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers . The EMBO journal 17 , 3385 - 3397 . Levkowitz , G . , Waterman , H . , Zamir , E . , Kam , Z . , Oved , S . , Langdon , W . Y . , Beguinot , L . , Geiger , B . , Yarden , Y . , 1998 . c - Cbl / Sli - 1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor . Genes & development 12 , 3663 - 3674 . Liccardi , G . , Hartley , J . A . , Hochhauser , D . , 2011 . EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment . Cancer Res 71 , 1103 - 1114 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Licitra , L . , Storkel , S . , Kerr , K . M . , Van Cutsem , E . , Pirker , R . , Hirsch , F . R . , Vermorken , J . B . , von Heydebreck , A . , Esser , R . , Celik , I . , Ciardiello , F . , 2013 . Predictive value of epidermal growth factor receptor expression for first - line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer : analysis of data from the EXTREME and CRYSTAL studies . European journal of cancer 49 , 1161 - 1168 . Lim , S . O . , Li , C . W . , Xia , W . , Lee , H . H . , Chang , S . S . , Shen , J . , Hsu , J . L . , Raftery , D . , Djukovic , D . , Gu , H . , Chang , W . C . , Wang , H . L . , Chen , M . L . , Huo , L . , Chen , C . H . , Wu , Y . , Sahin , A . , Hanash , S . M . , Hortobagyi , G . N . , Hung , M . C . , 2016 . EGFR Signaling Enhances Aerobic Glycolysis in Triple - Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape . Cancer Res 76 , 1284 - 1296 . Loerke , D . , Mettlen , M . , Yarar , D . , Jaqaman , K . , Jaqaman , H . , Danuser , G . , Schmid , S . L . , 2009 . Cargo and dynamin regulate clathrin - coated pit maturation . PLoS Biol 7 , e57 . Luetteke , N . C . , Phillips , H . K . , Qiu , T . H . , Copeland , N . G . , Earp , H . S . , Jenkins , N . A . , Lee , D . C . , 1994 . The mouse waved - 2 phenotype results from a point mutation in the EGF receptor tyrosine kinase . Genes Dev 8 , 399 - 413 . Makinoshima , H . , Takita , M . , Matsumoto , S . , Yagishita , A . , Owada , S . , Esumi , H . , Tsuchihara , K . , 2014 . Epidermal growth factor receptor ( EGFR ) signaling regulates global metabolic pathways in EGFR - mutated lung adenocarcinoma . J Biol Chem 289 , 20813 - 20823 . Makinoshima , H . , Takita , M . , Saruwatari , K . , Umemura , S . , Obata , Y . , Ishii , G . , Matsumoto , S . , Sugiyama , E . , Ochiai , A . , Abe , R . , Goto , K . , Esumi , H . , Tsuchihara , K . , 2015 . Signaling through the Phosphatidylinositol 3 - Kinase ( PI3K ) / Mammalian Target of Rapamycin ( mTOR ) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor ( EGFR ) - mutated Lung Adenocarcinoma . J Biol Chem 290 , 17495 - 17504 . Mancini , M . , Yarden , Y . , 2016 . Mutational and network level mechanisms underlying resistance to anti - cancer kinase inhibitors . Semin Cell Dev Biol 50 , 164 - 176 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Masui , K . , Cavenee , W . K . , Mischel , P . S . , 2014 . mTORC2 in the center of cancer metabolic reprogramming . Trends Endocrinol Metab 25 , 364 - 373 . McMahon , H . T . , Boucrot , E . , 2011 . Molecular mechanism and physiological functions of clathrin - mediated endocytosis . Nature reviews . Molecular cell biology 12 , 517 - 533 . Mellman , I . , Yarden , Y . , 2013 . Endocytosis and cancer . Cold Spring Harb Perspect Biol 5 , a016949 . Menzies , F . M . , Fleming , A . , Rubinsztein , D . C . , 2015 . Compromised autophagy and neurodegenerative diseases . Nat Rev Neurosci 16 , 345 - 357 . Miettinen , P . J . , Berger , J . E . , Meneses , J . , Phung , Y . , Pedersen , R . A . , Werb , Z . , Derynck , R . , 1995 . Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor . Nature 376 , 337 - 341 . Miller , S . E . , Mathiasen , S . , Bright , N . A . , Pierre , F . , Kelly , B . T . , Kladt , N . , Schauss , A . , Merrifield , C . J . , Stamou , D . , Honing , S . , Owen , D . J . , 2015 . CALM regulates clathrin - coated vesicle size and maturation by directly sensing and driving membrane curvature . Dev Cell 33 , 163 - 175 . Mills , G . B . , Jurisica , I . , Yarden , Y . , Norman , J . C . , 2009 . Genomic amplicons target vesicle recycling in breast cancer . J Clin Invest 119 , 2123 - 2127 . Montagut , C . , Dalmases , A . , Bellosillo , B . , Crespo , M . , Pairet , S . , Iglesias , M . , Salido , M . , Gallen , M . , Marsters , S . , Tsai , S . P . , Minoche , A . , Seshagiri , S . , Somasekar , S . , Serrano , S . , Himmelbauer , H . , Bellmunt , J . , Rovira , A . , Settleman , J . , Bosch , F . , Albanell , J . , 2012 . Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer . Nat Med 18 , 221 - 223 . Mosesson , Y . , Mills , G . B . , Yarden , Y . , 2008 . Derailed endocytosis : an emerging feature of cancer . Nat Rev Cancer 8 , 835 - 850 . Nagel , R . , Semenova , E . A . , Berns , A . , 2016 . Drugging the addict : non - oncogene addiction as a target for cancer therapy . EMBO Rep 17 , 1516 - 1531 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Oksvold , M . P . , Huitfeldt , H . S . , Ostvold , A . C . , Skarpen , E . , 2002 . UV induces tyrosine kinase - independent internalisation and endosome arrest of the EGF receptor . J Cell Sci 115 , 793 - 803 . Oksvold , M . P . , Thien , C . B . , Widerberg , J . , Chantry , A . , Huitfeldt , H . S . , Langdon , W . Y . , 2004 . UV - radiation - induced internalization of the epidermal growth factor receptor requires distinct serine and tyrosine residues in the cytoplasmic carboxy - terminal domain . Radiat Res 161 , 685 - 691 . Orth , J . D . , Krueger , E . W . , Weller , S . G . , McNiven , M . A . , 2006 . A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization . Cancer research 66 , 3603 - 3610 . Pedersen , M . W . , Jacobsen , H . J . , Koefoed , K . , Hey , A . , Pyke , C . , Haurum , J . S . , Kragh , M . , 2010 . Sym004 : a novel synergistic anti - epidermal growth factor receptor antibody mixture with superior anticancer efficacy . Cancer research 70 , 588 - 597 . Peeters , M . , Karthaus , M . , Rivera , F . , Terwey , J . H . , Douillard , J . Y . , 2015 . Panitumumab in Metastatic Colorectal Cancer : The Importance of Tumour RAS Status . Drugs 75 , 731 - 748 . Phillips , M . J . , Voeltz , G . K . , 2016 . Structure and function of ER membrane contact sites with other organelles . Nature reviews . Molecular cell biology 17 , 69 - 82 . Pierotti , M . A . , Negri , T . , Tamborini , E . , Perrone , F . , Pricl , S . , Pilotti , S . , 2010 . Targeted therapies : the rare cancer paradigm . Molecular oncology 4 , 19 - 37 . Raiborg , C . , Stenmark , H . , 2009 . The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins . Nature 458 , 445 - 452 . Ravid , T . , Sweeney , C . , Gee , P . , Carraway , K . L . , 3rd , Goldkorn , T . , 2002 . Epidermal growth factor receptor activation under oxidative stress fails to promote c - Cbl mediated down - regulation . J Biol Chem 277 , 31214 - 31219 . Roepstorff , K . , Grandal , M . V . , Henriksen , L . , Knudsen , S . L . , Lerdrup , M . , Grovdal , L . , Willumsen , B . M . , van Deurs , B . , 2009 . Differential effects of EGFR ligands on endocytic sorting of the receptor . Traffic 10 , 1115 - 1127 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Roskoski , R . , Jr . , 2014 . The ErbB / HER family of protein - tyrosine kinases and cancer . Pharmacological research 79 , 34 - 74 . Rowland , A . A . , Chitwood , P . J . , Phillips , M . J . , Voeltz , G . K . , 2014 . ER contact sites define the position and timing of endosome fission . Cell 159 , 1027 - 1041 . Rubinsztein , D . C . , Codogno , P . , Levine , B . , 2012 . Autophagy modulation as a potential therapeutic target for diverse diseases . Nat Rev Drug Discov 11 , 709 - 730 . Saheki , Y . , De Camilli , P . , 2017 . Endoplasmic Reticulum - Plasma Membrane Contact Sites . Annu Rev Biochem 86 , 659 - 684 . Sawano , A . , Takayama , S . , Matsuda , M . , Miyawaki , A . , 2002 . Lateral propagation of EGF signaling after local stimulation is dependent on receptor density . Developmental cell 3 , 245 - 257 . Scharaw , S . , Iskar , M . , Ori , A . , Boncompain , G . , Laketa , V . , Poser , I . , Lundberg , E . , Perez , F . , Beck , M . , Bork , P . , Pepperkok , R . , 2016 . The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR . The Journal of cell biology 215 , 543 - 558 . Schlessinger , J . , 2014 . Receptor tyrosine kinases : legacy of the first two decades . Cold Spring Harbor perspectives in biology 6 . Schmid , S . L . , 2017 . Reciprocal regulation of signaling and endocytosis : Implications for the evolving cancer cell . J Cell Biol . Schmidt , M . H . , Furnari , F . B . , Cavenee , W . K . , Bogler , O . , 2003 . Epidermal growth factor receptor signaling intensity determines intracellular protein interactions , ubiquitination , and internalization . Proceedings of the National Academy of Sciences of the United States of America 100 , 6505 - 6510 . Schneider , M . R . , Yarden , Y . , 2016 . The EGFR - HER2 module : a stem cell approach to understanding a prime target and driver of solid tumors . Oncogene 35 , 2949 - 2960 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Shen , J . , Xia , W . , Khotskaya , Y . B . , Huo , L . , Nakanishi , K . , Lim , S . O . , Du , Y . , Wang , Y . , Chang , W . C . , Chen , C . H . , Hsu , J . L . , Wu , Y . , Lam , Y . C . , James , B . P . , Liu , X . , Liu , C . G . , Patel , D . J . , Hung , M . C . , 2013 . EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2 . Nature 497 , 383 - 387 . Shtiegman , K . , Kochupurakkal , B . S . , Zwang , Y . , Pines , G . , Starr , A . , Vexler , A . , Citri , A . , Katz , M . , Lavi , S . , Ben - Basat , Y . , Benjamin , S . , Corso , S . , Gan , J . , Yosef , R . B . , Giordano , S . , Yarden , Y . , 2007 . Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling . Oncogene 26 , 6968 - 6978 . Sibilia , M . , Wagner , E . F . , 1995 . Strain - dependent epithelial defects in mice lacking the EGF receptor . Science 269 , 234 - 238 . Sigismund , S . , Algisi , V . , Nappo , G . , Conte , A . , Pascolutti , R . , Cuomo , A . , Bonaldi , T . , Argenzio , E . , Verhoef , L . G . , Maspero , E . , Bianchi , F . , Capuani , F . , Ciliberto , A . , Polo , S . , Di Fiore , P . P . , 2013 . Threshold - controlled ubiquitination of the EGFR directs receptor fate . The EMBO journal 32 , 2140 - 2157 . Sigismund , S . , Argenzio , E . , Tosoni , D . , Cavallaro , E . , Polo , S . , Di Fiore , P . P . , 2008 . Clathrin - mediated internalization is essential for sustained EGFR signaling but dispensable for degradation . Dev Cell 15 , 209 - 219 . Sigismund , S . , Confalonieri , S . , Ciliberto , A . , Polo , S . , Scita , G . , Di Fiore , P . P . , 2012 . Endocytosis and signaling : cell logistics shape the eukaryotic cell plan . Physiological reviews 92 , 273 - 366 . Sigismund , S . , Woelk , T . , Puri , C . , Maspero , E . , Tacchetti , C . , Transidico , P . , Di Fiore , P . P . , Polo , S . , 2005 . Clathrin - independent endocytosis of ubiquitinated cargos . Proc Natl Acad Sci U S A 102 , 2760 - 2765 . Sorkin , A . , Carpenter , G . , 1993 . Interaction of activated EGF receptors with coated pit adaptins . Science 261 , 612 - 615 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Suetsugu , S . , Yamazaki , D . , Kurisu , S . , Takenawa , T . , 2003 . Differential roles of WAVE1 and WAVE2 in dorsal and peripheral ruffle formation for fibroblast cell migration . Dev Cell 5 , 595 - 609 . Szumiel , I . , 2006 . Epidermal growth factor receptor and DNA double strand break repair : the cell ' s self - defence . Cell Signal 18 , 1537 - 1548 . Tan , X . , Lambert , P . F . , Rapraeger , A . C . , Anderson , R . A . , 2016a . Stress - Induced EGFR Trafficking : Mechanisms , Functions , and Therapeutic Implications . Trends Cell Biol 26 , 352 - 366 . Tan , X . , Sun , Y . , Thapa , N . , Liao , Y . , Hedman , A . C . , Anderson , R . A . , 2015a . LAPTM4B is a PtdIns ( 4 , 5 ) P2 effector that regulates EGFR signaling , lysosomal sorting , and degradation . EMBO J 34 , 475 - 490 . Tan , X . , Thapa , N . , Liao , Y . , Choi , S . , Anderson , R . A . , 2016b . PtdIns ( 4 , 5 ) P2 signaling regulates ATG14 and autophagy . Proc Natl Acad Sci U S A 113 , 10896 - 10901 . Tan , X . , Thapa , N . , Sun , Y . , Anderson , R . A . , 2015b . A kinase - independent role for EGF receptor in autophagy initiation . Cell 160 , 145 - 160 . Thatcher , N . , Chang , A . , Parikh , P . , Rodrigues Pereira , J . , Ciuleanu , T . , von Pawel , J . , Thongprasert , S . , Tan , E . H . , Pemberton , K . , Archer , V . , Carroll , K . , 2005 . Gefitinib plus best supportive care in previously treated patients with refractory advanced non - small - cell lung cancer : results from a randomised , placebo - controlled , multicentre study ( Iressa Survival Evaluation in Lung Cancer ) . Lancet 366 , 1527 - 1537 . Threadgill , D . W . , Dlugosz , A . A . , Hansen , L . A . , Tennenbaum , T . , Lichti , U . , Yee , D . , LaMantia , C . , Mourton , T . , Herrup , K . , Harris , R . C . , et al . , 1995 . Targeted disruption of mouse EGF receptor : effect of genetic background on mutant phenotype . Science 269 , 230 - 234 . Tomas , A . , Futter , C . E . , Eden , E . R . , 2014 . EGF receptor trafficking : consequences for signaling and cancer . Trends Cell Biol 24 , 26 - 34 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Tomas , A . , Jones , S . , Vaughan , S . O . , Hochhauser , D . , Futter , C . E . , 2017 . Stress - specific p38 MAP kinase activation is sufficient to drive EGF receptor endocytosis but not nuclear translocation . J Cell Sci . Tomas , A . , Vaughan , S . O . , Burgoyne , T . , Sorkin , A . , Hartley , J . A . , Hochhauser , D . , Futter , C . E . , 2015 . WASH and Tsg101 / ALIX - dependent diversion of stress - internalized EGFR from the canonical endocytic pathway . Nat Commun 6 , 7324 . Tong , J . , Taylor , P . , Moran , M . F . , 2014 . Proteomic analysis of the epidermal growth factor receptor ( EGFR ) interactome and post - translational modifications associated with receptor endocytosis in response to EGF and stress . Mol Cell Proteomics 13 , 1644 - 1658 . Tsai , F . C . , Seki , A . , Yang , H . W . , Hayer , A . , Carrasco , S . , Malmersjo , S . , Meyer , T . , 2014 . A polarized Ca2 + , diacylglycerol and STIM1 signalling system regulates directed cell migration . Nat Cell Biol 16 , 133 - 144 . van Bergeijk , P . , Hoogenraad , C . C . , Kapitein , L . C . , 2016 . Right Time , Right Place : Probing the Functions of Organelle Positioning . Trends Cell Biol 26 , 121 - 134 . Van Emburgh , B . O . , Arena , S . , Siravegna , G . , Lazzari , L . , Crisafulli , G . , Corti , G . , Mussolin , B . , Baldi , F . , Buscarino , M . , Bartolini , A . , Valtorta , E . , Vidal , J . , Bellosillo , B . , Germano , G . , Pietrantonio , F . , Ponzetti , A . , Albanell , J . , Siena , S . , Sartore - Bianchi , A . , Di Nicolantonio , F . , Montagut , C . , Bardelli , A . , 2016 . Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer . Nat Commun 7 , 13665 . Vergarajauregui , S . , San Miguel , A . , Puertollano , R . , 2006 . Activation of p38 mitogen - activated protein kinase promotes epidermal growth factor receptor internalization . Traffic 7 , 686 - 698 . Villasenor , R . , Kalaidzidis , Y . , Zerial , M . , 2016 . Signal processing by the endosomal system . Current opinion in cell biology 39 , 53 - 60 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Villasenor , R . , Nonaka , H . , Del Conte - Zerial , P . , Kalaidzidis , Y . , Zerial , M . , 2015 . Regulation of EGFR signal transduction by analogue - to - digital conversion in endosomes . eLife 4 . Vincenzi , B . , Schiavon , G . , Silletta , M . , Santini , D . , Tonini , G . , 2008 . The biological properties of cetuximab . Crit Rev Oncol Hematol 68 , 93 - 106 . Waldhart , A . N . , Dykstra , H . , Peck , A . S . , Boguslawski , E . A . , Madaj , Z . B . , Wen , J . , Veldkamp , K . , Hollowell , M . , Zheng , B . , Cantley , L . C . , McGraw , T . E . , Wu , N . , 2017 . Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin . Cell Rep 19 , 2005 - 2013 . Wandinger - Ness , A . , Zerial , M . , 2014 . Rab proteins and the compartmentalization of the endosomal system . Cold Spring Harb Perspect Biol 6 , a022616 . Wanner , G . , Mayer , C . , Kehlbach , R . , Rodemann , H . P . , Dittmann , K . , 2008 . Activation of protein kinase Cepsilon stimulates DNA - repair via epidermal growth factor receptor nuclear accumulation . Radiother Oncol 86 , 383 - 390 . Waterman , H . , Alroy , I . , Strano , S . , Seger , R . , Yarden , Y . , 1999 . The C - terminus of the kinase - defective neuregulin receptor ErbB - 3 confers mitogenic superiority and dictates endocytic routing . EMBO J 18 , 3348 - 3358 . Waterman , H . , Katz , M . , Rubin , C . , Shtiegman , K . , Lavi , S . , Elson , A . , Jovin , T . , Yarden , Y . , 2002 . A mutant EGF - receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling . EMBO J 21 , 303 - 313 . Wei , Y . , Zou , Z . , Becker , N . , Anderson , M . , Sumpter , R . , Xiao , G . , Kinch , L . , Koduru , P . , Christudass , C . S . , Veltri , R . W . , Grishin , N . V . , Peyton , M . , Minna , J . , Bhagat , G . , Levine , B . , 2013 . EGFR - mediated Beclin 1 phosphorylation in autophagy suppression , tumor progression , and tumor chemoresistance . Cell 154 , 1269 - 1284 . Weihua , Z . , Tsan , R . , Huang , W . C . , Wu , Q . , Chiu , C . H . , Fidler , I . J . , Hung , M . C . , 2008 . Survival of cancer cells is maintained by EGFR independent of its kinase activity . Cancer Cell 13 , 385 - 393 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Wheeler , D . B . , Zoncu , R . , Root , D . E . , Sabatini , D . M . , Sawyers , C . L . , 2015 . Identification of an oncogenic RAB protein . Science 350 , 211 - 217 . Wieman , H . L . , Wofford , J . A . , Rathmell , J . C . , 2007 . Cytokine stimulation promotes glucose uptake via phosphatidylinositol - 3 kinase / Akt regulation of Glut1 activity and trafficking . Mol Biol Cell 18 , 1437 - 1446 . Wiley , H . S . , 1988 . Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system . The Journal of cell biology 107 , 801 - 810 . Wilson , K . J . , Gilmore , J . L . , Foley , J . , Lemmon , M . A . , Riese , D . J . , 2nd , 2009 . Functional selectivity of EGF family peptide growth factors : implications for cancer . Pharmacology & therapeutics 122 , 1 - 8 . Wilson , K . J . , Mill , C . , Lambert , S . , Buchman , J . , Wilson , T . R . , Hernandez - Gordillo , V . , Gallo , R . M . , Ades , L . M . , Settleman , J . , Riese , D . J . , 2nd , 2012 . EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling . Growth factors 30 , 107 - 116 . Wofford , J . A . , Wieman , H . L . , Jacobs , S . R . , Zhao , Y . , Rathmell , J . C . , 2008 . IL - 7 promotes Glut1 trafficking and glucose uptake via STAT5 - mediated activation of Akt to support T - cell survival . Blood 111 , 2101 - 2111 . Wollert , T . , Yang , D . , Ren , X . , Lee , H . H . , Im , Y . J . , Hurley , J . H . , 2009 . The ESCRT machinery at a glance . J Cell Sci 122 , 2163 - 2166 . Yang , Y . P . , Ma , H . , Starchenko , A . , Huh , W . J . , Li , W . , Hickman , F . E . , Zhang , Q . , Franklin , J . L . , Mortlock , D . P . , Fuhrmann , S . , Carter , B . D . , Ihrie , R . A . , Coffey , R . J . , 2017 . A Chimeric Egfr Protein Reporter Mouse Reveals Egfr Localization and Trafficking In Vivo . Cell Rep 19 , 1257 - 1267 . Yarden , Y . , Pines , G . , 2012 . The ERBB network : at last , cancer therapy meets systems biology . Nature reviews . Cancer 12 , 553 - 563 . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . Yun , C . H . , Boggon , T . J . , Li , Y . , Woo , M . S . , Greulich , H . , Meyerson , M . , Eck , M . J . , 2007 . Structures of lung cancer - derived EGFR mutants and inhibitor complexes : mechanism of activation and insights into differential inhibitor sensitivity . Cancer Cell 11 , 217 - 227 . Zhang , J . , Song , F . , Zhao , X . , Jiang , H . , Wu , X . , Wang , B . , Zhou , M . , Tian , M . , Shi , B . , Wang , H . , Jia , Y . , Pan , X . , Li , Z . , 2017 . EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer . Mol Cancer 16 , 127 . Zhang , X . , Gureasko , J . , Shen , K . , Cole , P . A . , Kuriyan , J . , 2006 . An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor . Cell 125 , 1137 - 1149 . Zhu , H . , Cao , X . , Ali - Osman , F . , Keir , S . , Lo , H . W . , 2010 . EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA - mediated apoptosis independent of EGFR kinase activity . Cancer Lett 294 , 101 - 110 . Zwang , Y . , Yarden , Y . , 2006 . p38 MAP kinase mediates stress - induced internalization of EGFR : implications for cancer chemotherapy . EMBO J 25 , 4195 - 4206 . Figure Legends Figure 1 . Scheme of EGFR and its mutations in glioblastoma and in lung and colorectal cancer A ) Schematic representation of the EGFR and EGF - induced receptor activation . The EGFR extracellular region encompasses domains I , II , III and IV ; following are : the transmembrane region ( TM ) , the intracellular juxtamembrane domain ( iJM ) , the tyrosine kinase domain ( TK ) and the carboxyl terminal tail ( Carboxy tail ) . EGF binding to the receptor unmasks a dimerization motif and determines structural rearrangements that are conveyed to the cytoplasmic domain allowing the formation of asymmetric dimers between the two juxtaposed catalytic domains . Adapted from ( Zhang et al . , 2006 ) . B ) Most frequent EGFR mutations in glioblastoma , NSCLC ( non small cell lung cancer ) and in CRC ( colorectal cancer ) . Adapted from ( Imai and Takaoka , 2006 ) . Mutations found in tumors A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . resistant to EGFR blockade are shown in red . In CRC , the indicated EGFR mutations have been identified in patients that progressed upon cetuximab treatment ( Arena et al . , 2015 ; Arena et al . , 2016 ; Montagut et al . , 2012 ; Van Emburgh et al . , 2016 ) . Figure 2 . Active and inactive EGFR - related functions This picture schematizes some non - canonical EGFR functions . From left to right : EGFR stimulated with high EGF doses ( Active EGFR ) is phosphorylated ( P ) and ubiquitinated ( Ub ) and undergoes both clathrin - mediated endocytosis ( not depicted ) and non - clathrin dependent endocytosis ( NCE ) , the latter dependent on the formation of RTN3 - mediated ER - PM contact sites . This is accompanied by calcium release in the proximity of contact sites , which likely controls fission of the tubular invagination . It is still unclear whether RTN3 is the tethering factor between the ER and the PM ( as depicted ) , or it is just involved the tubulation of cortical ER , but not directly engaged at contact sites . EGFR ligand stimulation elicits the classical signaling cascade based on the recruitment of PI3K ( made of its p85 regulatory subunit and p110 catalytic subunit ) that catalyzes the formation of PIP3s . PIP3s bind to the PH domain of AKT and of Phosphoinositide - dependent kinase - 1 , PDK1 . PDK1 phosphorylates AKT on Thr 308 , while mammalian target of rapamycin complex 2 , mTORC2 ( not depicted here ) is responsible for phosphorylation on Ser 473 , leading to full AKT activation . Active AKT inhibits autophagy and blocks GLUT1 endocytosis . This latter function leads to higher levels of GLUT1 at the plasma membrane , increasing the uptake of glucose . In addition , ligand - independent direct interaction of EGFR ( Inactive EGFR ) and GLUT1 also stabilizes the glucose transporter at the cell surface promoting high glucose uptake . Ligand - unbound EGFR constitutively internalizes into early and late endosomes where it is sequestered by LAPTM4B . Here , the inactive EGFR interacts with Rubicon causing its dissociation from Beclin1 . Beclin1 complex can now initiates autophagy on the ER membrane . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . List of abbreviations EGFR Epidermal Growth Factor Receptor ErbB Erythroblastosis oncogene B RTK Receptor Tyrosine Kinase PM Plasma Membrane Cbl Cellular homologue of Cas NS - 1 oncogene TGF  Transforming Growth Factor  Grb2 Growth Factor Receptor - bound protein 2 EGF Epidermal Growth Factor NCE Non - Clathrin Endocytosis Ras Retrovirus - associated DNA sequence MAPK Mitogen - Activated Protein Kinase PI3K Phosphoinositide 3 kinase AKT AKT8 virus oncogene cellular homolog PLC Phospholipase C PKC Protein kinase C CME Clathrin - Mediated Endocytosis AP2 Adaptor Protein 2 CCP Clathrin - Coated Pit NSCLC Non Small Cell Lung Cancer Dyn1 Dynamin 1 CLCb Clathrin Light Chain b ER Endoplasmic Reticulum RTN3 Reticulon 3 FEME Endophilin - Mediated Endocytosis GPCR G - Protein - Coupled Receptor A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . EE Early Endosome ESCRT Endosomal Sorting Complex Required for Transport MVB Multivesicular Body RNF11 Ring Finger protein 11 Rab Ras analog in the brain SYNJ2 5 ′ - inositol lipid phosphatase Synaptojanin 2 KO Knock Out KI Knock In Src Rous sarcoma oncogene cellular homolog PTP1B Protein Phosphotyrosilphosphatase 1B Ca 2 + Calcium ion TPC Two - Pore Channel UV Ultra Violet TNF  Tumor Necrosis Factor  c - MET MET proto - oncogene receptor tyrosine kinase TfR Transferrin Receptor ILV Intraluminal Vesicle AGO2 Argonaute 2 miRNA Micro - Ribonucleic Acid PKC  Protein Kinase C  VPS34 Vacuolar protein sorting 34 mTORC1 Mammalian Target of Rapamycin Complex 1 LAPTM4B Lysosomal - Associated Protein Transmembrane 4 Beta PDGFR Platelet Derived Growth Factor Receptor FGFR2 Fibroblast Growth Factor Receptor 2 ATG14 Autophagy related gene 14 PIPKI  i5 Phosphatidylinositol - 4 - Phosphate 5 - Kinase type Iγ A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . PIP 2 Phosphatidylinositol 4 , 5 - bisphosphate LC3 Microtubule - associated proteins 1A / 1B light chain 3B LIR LC3 - Interacting Region PUMA p53 - Upregulated Modulator of Apoptosis Bcl - 2 B - cell lymphoma gene 2 MYC Myelocytomatosis oncogene cellular homolog SREBP - 1 Sterol Regulatory Element - Binding Protein 1 LDLR Low Density Lipoprotein Receptor SCD1 Stearoyl - CoA Desaturase - 1 GLUT1 Glucose Transporter Type 1 GLUT3 Glucose Transporter Type 3 HK1 Hexokinase 1 PKM2 Pyruvate kinase M2 TXNIP Thioredoxin - Interacting Protein mAb Monoclonal antibody BRAF v - Raf murine sarcoma viral oncogene homolog B CRC Colorectal Cancer PDK1 Phosphoinositide - dependent Kinase - 1 mTORC2 Mammalian Target of Rapamycin Complex 2 A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd . A c c e p t e d A r t i c l e Molecular Oncology ( 2017 ) © 2017 The Authors . Published by FEBS Press and John Wiley & Sons Ltd .